Rohit Nathani

Chief Resident

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rohit Nathani is the Chief Resident at Mount Sinai West and Morningside, USA. His research areas include metabolic liver diseases, outcomes related to liver transplantation, and the impact of co-infections on liver disease management. His recent publications focus on various aspects of liver health and transplantation, including cost implications of guidelines, predictive factors for survival, and the role of biomarkers in monitoring alcohol consumption.

Articles (7)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Collaborators (1)

Adam Winters

Assistant Professor of Medicine

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rohit Nathani

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Real-World Cost Implications of American Association for the Study of Liver Diseases/American Gastroenterological Association Metabolic Dysfunction-associated Steatotic Liver Disease Guidance for Patients with Diabetes, and Factors Associated With Advanced Fibrosis

Age added to MELD or ACLF predicts survival in patients with alcohol-associated hepatitis declined for liver transplantation

Acquired Immunodeficiency Syndrome Cholangiopathy in the Highly Active Antiretroviral Therapy Era

Outcomes after kidney transplant alone in patients with cirrhosis—A case‐control study

Universal alcohol biomarker monitoring improves drinking detection and accountability during evaluation for liver transplantation

The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection.

Presence of Ascites at Presentation is Associated With Absence of Long-Term Response Amongst Patients With Budd-Chiari Syndrome When Treated With Medical Therapy Alone: A Single Centre Real-Life Experience.

Collaborators (1)

Adam Winters

Make your next move.